Prof Ken Pang
Prof Ken Pang
Details
Role
Group Leader / Snr Princ Research Fellow
Research area
Clinical Sciences
Group
Transgender Health
Ken Pang is a consultant paediatrician and biomedical researcher.
Clinically, he graduated in medicine from the University of Melbourne as valedictorian at The Royal Melbourne Hospital (RCH), trained in paediatrics and child psychiatry, and now works with young trans and gender diverse individuals at the Royal Children’s Hospital in Melbourne.
As a researcher, Ken undertook his PhD in genomics and immunology at the University of Melbourne, before completing postdoctoral studies in genetics at Harvard University as a Fulbright Scholar and National Health and Medical Research Council (NHMRC) CJ Martin/RG Menzies Fellow. After returning to Australia, he continued this research at the Walter and Eliza Hall Institute for Medical Research, which led to his team receiving the Victorian Premier’s Award for Medical Research (Basic Science).
Since joining the Murdoch Children's Research Institute in 2016 as one of its inaugural Clinician Scientist Fellows, Ken’s research has shifted focus, with the goal of his team now aimed at improving the health of transgender and gender diverse children and adolescents. To this end, his team has now published >30 articles on transgender health across various journals such as the BMJ, JAMA Pediatrics, Lancet Child and Adolescent Health, and Pediatrics.
Clinically, he graduated in medicine from the University of Melbourne as valedictorian at The Royal Melbourne Hospital (RCH), trained in paediatrics and child psychiatry, and now works with young trans and gender diverse individuals at the Royal Children’s Hospital in Melbourne.
As a researcher, Ken undertook his PhD in genomics and immunology at the University of Melbourne, before completing postdoctoral studies in genetics at Harvard University as a Fulbright Scholar and National Health and Medical Research Council (NHMRC) CJ Martin/RG Menzies Fellow. After returning to Australia, he continued this research at the Walter and Eliza Hall Institute for Medical Research, which led to his team receiving the Victorian Premier’s Award for Medical Research (Basic Science).
Since joining the Murdoch Children's Research Institute in 2016 as one of its inaugural Clinician Scientist Fellows, Ken’s research has shifted focus, with the goal of his team now aimed at improving the health of transgender and gender diverse children and adolescents. To this end, his team has now published >30 articles on transgender health across various journals such as the BMJ, JAMA Pediatrics, Lancet Child and Adolescent Health, and Pediatrics.
Ken Pang is a consultant paediatrician and biomedical researcher.
Clinically, he graduated in medicine from the University of Melbourne as valedictorian at The Royal Melbourne Hospital (RCH), trained in paediatrics and child psychiatry, and now...
Clinically, he graduated in medicine from the University of Melbourne as valedictorian at The Royal Melbourne Hospital (RCH), trained in paediatrics and child psychiatry, and now...
Ken Pang is a consultant paediatrician and biomedical researcher.
Clinically, he graduated in medicine from the University of Melbourne as valedictorian at The Royal Melbourne Hospital (RCH), trained in paediatrics and child psychiatry, and now works with young trans and gender diverse individuals at the Royal Children’s Hospital in Melbourne.
As a researcher, Ken undertook his PhD in genomics and immunology at the University of Melbourne, before completing postdoctoral studies in genetics at Harvard University as a Fulbright Scholar and National Health and Medical Research Council (NHMRC) CJ Martin/RG Menzies Fellow. After returning to Australia, he continued this research at the Walter and Eliza Hall Institute for Medical Research, which led to his team receiving the Victorian Premier’s Award for Medical Research (Basic Science).
Since joining the Murdoch Children's Research Institute in 2016 as one of its inaugural Clinician Scientist Fellows, Ken’s research has shifted focus, with the goal of his team now aimed at improving the health of transgender and gender diverse children and adolescents. To this end, his team has now published >30 articles on transgender health across various journals such as the BMJ, JAMA Pediatrics, Lancet Child and Adolescent Health, and Pediatrics.
Clinically, he graduated in medicine from the University of Melbourne as valedictorian at The Royal Melbourne Hospital (RCH), trained in paediatrics and child psychiatry, and now works with young trans and gender diverse individuals at the Royal Children’s Hospital in Melbourne.
As a researcher, Ken undertook his PhD in genomics and immunology at the University of Melbourne, before completing postdoctoral studies in genetics at Harvard University as a Fulbright Scholar and National Health and Medical Research Council (NHMRC) CJ Martin/RG Menzies Fellow. After returning to Australia, he continued this research at the Walter and Eliza Hall Institute for Medical Research, which led to his team receiving the Victorian Premier’s Award for Medical Research (Basic Science).
Since joining the Murdoch Children's Research Institute in 2016 as one of its inaugural Clinician Scientist Fellows, Ken’s research has shifted focus, with the goal of his team now aimed at improving the health of transgender and gender diverse children and adolescents. To this end, his team has now published >30 articles on transgender health across various journals such as the BMJ, JAMA Pediatrics, Lancet Child and Adolescent Health, and Pediatrics.
Top Publications
- Yong, MK, Thursky, K, Crane, M, Spelman, T, Mahar, RK, Simpson, JA, Scott, AM, Harrison, SJ, Szer, J, Pellegrini, M, et al. Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.. Clin Infect Dis 82(2) : e208 -e216 2026 view publication
- Van den Eynde, BJ, Pang, KC, Chen, W. Tumour Antigens Recognized by T Lymphocytes. 2026 view publication
- Pang, KC, Van den Eynde, BJ, van der Bruggen, P, Chen, W. Tumour Antigens Recognised by T Lymphocytes. 2026 view publication
- Nguyen, TA, Bieging-Rolett, KT, Putoczki, TL, Wicks, IP, Attardi, LD, Pang, KC. SIDT2 RNA transporter promotes lung and gastrointestinal tumor development. 2026 view publication
- Tong, J, Lee, KM, Liu, X, Nefzger, CM, Vijayakumar, P, Hawi, Z, Pang, KC, Parish, CL, Polo, JM, Bellgrove, MA. Generation of four iPSC lines from peripheral blood mononuclear cells (PBMCs) of an Attention Deficit Hyperactivity Disorder (ADHD) individual and a healthy sibling in an Australia-Caucasian family. 2026 view publication
Page 1 of 30
Career information
Share //
